Skip to main content
Top
Published in: Diabetes Therapy 2/2020

Open Access 01-02-2020 | Type 2 Diabetes | Original Research

Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes

Authors: Alireza Mirahmadizadeh, Haniyeh Khorshidsavar, Mozhgan Seif, Mohammad Hossein Sharifi

Published in: Diabetes Therapy | Issue 2/2020

Login to get access

Abstract

Introduction

The prevalence of type 2 diabetes mellitus (T2D) has increased considerably while the outcome of diabetic management is suboptimal. In order to promote diabetic management, associated factors for adherence to medications, diet, and physical activity (PA) need to be more clearly identified amongst patients with T2D.

Methods

This cross-sectional study was conducted on 206 men and 294 women amongst patients with diabetes who were registered in ten special diabetic clinics in Shiraz, Iran from November 2018 to April 2019. Levels of adherence to medication, Mediterranean diet (MD), and physical activity were measured with validated and appropriate questionnaires.

Results

Mean age (± SD) was 56.92 ± 0.52 years and 294 (58.8%) were female. Data showed that reduced adherence to medication, MD, and PA increased glycated hemoblobin (HbA1c). Adherence to medication among low, moderate, and high levels was 27.2%, 59.2%, and 13.6%, respectively. Associated factors such as 50–64 years of age, at least 65 years of age, overweight, obese, divorced widow, smoker, and ex-smoker had a significant influence on adherence to medication, P = 0.017, P = 0.018, P = 0.008. P = 0.045, P = 0.026, P < 0.004, and P = 0.001, respectively. In addition, adherence to MD among low, moderate, and high levels was 5.4%, 77.2%, and 17.4%, respectively. Associated factors such as 50–64 years of age, at least 65 years of age, overweight, obese, and smoker had a significant influence on adherence to MD, P = 0.011, P = 0.046, P = 0.002, P < 0.001, and P = 0.032, respectively. Furthermore, adherence to PA among low, moderate, and high levels was 21%, 68.6%, and 10.4%, respectively. Only the non-smoker factor played a significant role in PA adherence, P = 0.010.

Conclusion

Levels of adherence to medications, diet, and PA amongst patients with T2D are not within the acceptable range. Recognized associated factors that contribute to adherence might improve diabetes management and allow one to tailor the appropriate message to improve glycemic indices.
Literature
1.
go back to reference Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88.CrossRef Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88.CrossRef
2.
go back to reference Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005;36(3):300–6.CrossRef Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005;36(3):300–6.CrossRef
3.
go back to reference Cho N, Shaw J, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRef Cho N, Shaw J, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRef
4.
go back to reference Ahmed NO, Abugalambo S, Almethen GH. Adherence to oral hypoglycemic medication among patients with diabetes in Saudi Arabia. Int J Health Sci. 2017;11(3):45. Ahmed NO, Abugalambo S, Almethen GH. Adherence to oral hypoglycemic medication among patients with diabetes in Saudi Arabia. Int J Health Sci. 2017;11(3):45.
5.
go back to reference Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. Medications adherence and associated factors among patients with type 2 diabetes mellitus in the Gaza Strip, Palestine. Front Endocrinol. 2017;8:100.CrossRef Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. Medications adherence and associated factors among patients with type 2 diabetes mellitus in the Gaza Strip, Palestine. Front Endocrinol. 2017;8:100.CrossRef
6.
go back to reference Esposito K, Maiorino M, Di Palo C, Giugliano D, Campanian Postprandial Hyperglycemia Study Group. Adherence to a Mediterranean diet and glycaemic control in type 2 diabetes mellitus. Diabet Med. 2009;26(9):900–7.CrossRef Esposito K, Maiorino M, Di Palo C, Giugliano D, Campanian Postprandial Hyperglycemia Study Group. Adherence to a Mediterranean diet and glycaemic control in type 2 diabetes mellitus. Diabet Med. 2009;26(9):900–7.CrossRef
7.
go back to reference Schwingshackl L, Missbach B, König J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1292–9.CrossRef Schwingshackl L, Missbach B, König J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1292–9.CrossRef
8.
go back to reference Tobias Ferrer J, Santasusana Riera I, Cuadrench Solórzano M, Gonzalez Cabré M, Girbau Tapias M, Sant Masoliver C. Adherence to the Mediterranean diet in patients with coronary artery disease. Rev Esp Cardiol (Engl Ed). 2015;68(1):73–5.CrossRef Tobias Ferrer J, Santasusana Riera I, Cuadrench Solórzano M, Gonzalez Cabré M, Girbau Tapias M, Sant Masoliver C. Adherence to the Mediterranean diet in patients with coronary artery disease. Rev Esp Cardiol (Engl Ed). 2015;68(1):73–5.CrossRef
9.
go back to reference Esposito K, Maiorino MI, Ciotola M, et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Obstet Gynecol Surv. 2010;65(6):379–80.CrossRef Esposito K, Maiorino MI, Ciotola M, et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Obstet Gynecol Surv. 2010;65(6):379–80.CrossRef
10.
go back to reference Forechi L, Mill JG, Griep RH, Santos I, Pitanga F, Molina MDCB. Adherence to physical activity in adults with chronic diseases: ELSA-Brasil. Rev Saude Publica. 2018;52:31.CrossRef Forechi L, Mill JG, Griep RH, Santos I, Pitanga F, Molina MDCB. Adherence to physical activity in adults with chronic diseases: ELSA-Brasil. Rev Saude Publica. 2018;52:31.CrossRef
11.
go back to reference Saint-Maurice PF, Troiano RP, Matthews CE, Kraus WE. Moderate-to-vigorous physical activity and all-cause mortality: do bouts matter? J Am Heart Assoc. 2018;7(6):e007678.CrossRef Saint-Maurice PF, Troiano RP, Matthews CE, Kraus WE. Moderate-to-vigorous physical activity and all-cause mortality: do bouts matter? J Am Heart Assoc. 2018;7(6):e007678.CrossRef
12.
go back to reference Sigal RJ, Armstrong MJ, Bacon SL, et al. Physical activity and diabetes. Can J Diabetes. 2018;42:S54–63.CrossRef Sigal RJ, Armstrong MJ, Bacon SL, et al. Physical activity and diabetes. Can J Diabetes. 2018;42:S54–63.CrossRef
13.
go back to reference Bullard T, Ji M, An R, Trinh L, Mackenzie M, Mullen SP. A systematic review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes. BMC Public Health. 2019;19(1):636.CrossRef Bullard T, Ji M, An R, Trinh L, Mackenzie M, Mullen SP. A systematic review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes. BMC Public Health. 2019;19(1):636.CrossRef
14.
go back to reference Qiu S-H, Sun Z-L, Cai X, Liu L, Yang B. Improving patients’ adherence to physical activity in diabetes mellitus: a review. Diabetes Metab J. 2012;36(1):1–5.CrossRef Qiu S-H, Sun Z-L, Cai X, Liu L, Yang B. Improving patients’ adherence to physical activity in diabetes mellitus: a review. Diabetes Metab J. 2012;36(1):1–5.CrossRef
15.
go back to reference Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–70.CrossRef Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–70.CrossRef
16.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. Abingdon: Routledge; 2013.CrossRef Cohen J. Statistical power analysis for the behavioral sciences. Abingdon: Routledge; 2013.CrossRef
17.
go back to reference Montgomery DC. Design and analysis of experiments. New York: Wiley; 2017. Montgomery DC. Design and analysis of experiments. New York: Wiley; 2017.
18.
go back to reference Rodríguez-Ortiz D, Reyes-Pérez A, León P, et al. Assessment of two different diagnostic guidelines criteria (National Cholesterol Education Adult Treatment Panel III [ATP III] and International Diabetes Federation [IDF]) for the evaluation of metabolic syndrome remission in a longitudinal cohort of patients undergoing Roux-en-Y gastric bypass. Surgery. 2016;159(4):1121–8.CrossRef Rodríguez-Ortiz D, Reyes-Pérez A, León P, et al. Assessment of two different diagnostic guidelines criteria (National Cholesterol Education Adult Treatment Panel III [ATP III] and International Diabetes Federation [IDF]) for the evaluation of metabolic syndrome remission in a longitudinal cohort of patients undergoing Roux-en-Y gastric bypass. Surgery. 2016;159(4):1121–8.CrossRef
19.
go back to reference Ghanei Gheshlagh R, Ebadi A, Veisi Raygani A, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. Iran J Rehabil Res Nurs. 2015;1(3):24–32. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani A, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. Iran J Rehabil Res Nurs. 2015;1(3):24–32.
20.
go back to reference Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G. Medication adherence and its related factors in patients with type II diabetes. J Educ Community Health. 2016;2(4):3–12.CrossRef Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G. Medication adherence and its related factors in patients with type II diabetes. J Educ Community Health. 2016;2(4):3–12.CrossRef
22.
go back to reference Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073–80. Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073–80.
23.
go back to reference Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.CrossRef Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.CrossRef
25.
go back to reference Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299.CrossRef Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299.CrossRef
26.
go back to reference Doggrell SA, Warot S. The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. Int J Clin Pharm. 2014;36(3):488–97.CrossRef Doggrell SA, Warot S. The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. Int J Clin Pharm. 2014;36(3):488–97.CrossRef
27.
go back to reference Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;7:525.PubMedPubMedCentral Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;7:525.PubMedPubMedCentral
28.
go back to reference Chew B-H, Hassan N-H, Sherina M-S. Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study. Patient Prefer Adherence. 2015;9:639.CrossRef Chew B-H, Hassan N-H, Sherina M-S. Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study. Patient Prefer Adherence. 2015;9:639.CrossRef
29.
go back to reference Waari G, Mutai J, Gikunju J. Medication adherence and factors associated with poor adherence among type 2 diabetes mellitus patients on follow-up at Kenyatta National Hospital, Kenya. Pan Afr Med J. 2018;29(1):1–15. Waari G, Mutai J, Gikunju J. Medication adherence and factors associated with poor adherence among type 2 diabetes mellitus patients on follow-up at Kenyatta National Hospital, Kenya. Pan Afr Med J. 2018;29(1):1–15.
30.
go back to reference Grandy S, Fox KM, Hardy E, SHIELD Study Group. Association of weight loss and medication adherence among adults with type 2 diabetes mellitus: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). Curr Ther Res. 2013;75:77–82.CrossRef Grandy S, Fox KM, Hardy E, SHIELD Study Group. Association of weight loss and medication adherence among adults with type 2 diabetes mellitus: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). Curr Ther Res. 2013;75:77–82.CrossRef
31.
go back to reference Quek YH, Tam WW, Zhang MW, Ho RC. Exploring the association between childhood and adolescent obesity and depression: a meta-analysis. Obes Rev. 2017;18(7):742–54.CrossRef Quek YH, Tam WW, Zhang MW, Ho RC. Exploring the association between childhood and adolescent obesity and depression: a meta-analysis. Obes Rev. 2017;18(7):742–54.CrossRef
32.
go back to reference Tiv M, Viel J-F, Mauny F, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS One. 2012;7(3):e32412.CrossRef Tiv M, Viel J-F, Mauny F, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS One. 2012;7(3):e32412.CrossRef
33.
go back to reference Mashrouteh M, Khanjani N, Gozashti MH. Evaluation of compliance with drug regimens in diabetic patients referred to the endocrinology clinic of Afzalipour Hospital, Kerman, Iran. J Health Dev. 2012;1(3):182–92. Mashrouteh M, Khanjani N, Gozashti MH. Evaluation of compliance with drug regimens in diabetic patients referred to the endocrinology clinic of Afzalipour Hospital, Kerman, Iran. J Health Dev. 2012;1(3):182–92.
34.
go back to reference Sherman BW, Lynch WD. The association of smoking with medical treatment adherence in the workforce of a large employer. Patient Prefer Adherence. 2014;8:477.CrossRef Sherman BW, Lynch WD. The association of smoking with medical treatment adherence in the workforce of a large employer. Patient Prefer Adherence. 2014;8:477.CrossRef
35.
go back to reference Mahdavi-Roshan M, Salari A, Gholipour M, Naghshbandi M. Dietary adherence in people with cardiovascular risk factors living in northern Iran. J Babol Univ Med Sci. 2017;19(1910):62–8. Mahdavi-Roshan M, Salari A, Gholipour M, Naghshbandi M. Dietary adherence in people with cardiovascular risk factors living in northern Iran. J Babol Univ Med Sci. 2017;19(1910):62–8.
36.
go back to reference Martin-Calvo N, Chavarro JE, Falbe J, Hu FB, Field AE. Adherence to the Mediterranean dietary pattern and BMI change among US adolescents. Int J Obes (Lond). 2016;40(7):1103.CrossRef Martin-Calvo N, Chavarro JE, Falbe J, Hu FB, Field AE. Adherence to the Mediterranean dietary pattern and BMI change among US adolescents. Int J Obes (Lond). 2016;40(7):1103.CrossRef
37.
go back to reference Inan-Eroglu E, Çetin C, Mutlu AA, Ayaz A, Samur G. Does adherence to Mediterranean diet affect body mass index and dietary macronutrient intakes in adults? Clin Nutr. 2018;37:S112.CrossRef Inan-Eroglu E, Çetin C, Mutlu AA, Ayaz A, Samur G. Does adherence to Mediterranean diet affect body mass index and dietary macronutrient intakes in adults? Clin Nutr. 2018;37:S112.CrossRef
38.
go back to reference Parajuli J, Saleh F, Thapa N, Ali L. Factors associated with nonadherence to diet and physical activity among Nepalese type 2 diabetes patients; a cross sectional study. BMC Res Notes. 2014;7(1):758.CrossRef Parajuli J, Saleh F, Thapa N, Ali L. Factors associated with nonadherence to diet and physical activity among Nepalese type 2 diabetes patients; a cross sectional study. BMC Res Notes. 2014;7(1):758.CrossRef
39.
go back to reference Albuquerque C, Correia C, Ferreira M. Adherence to the therapeutic regime in person with type 2 diabetes. Procedia-Social and Behavioral Sciences. 2015;171:350–8.CrossRef Albuquerque C, Correia C, Ferreira M. Adherence to the therapeutic regime in person with type 2 diabetes. Procedia-Social and Behavioral Sciences. 2015;171:350–8.CrossRef
40.
go back to reference Aune D, Schlesinger S, Norat T, Riboli E. Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2018;28(6):543–56.CrossRef Aune D, Schlesinger S, Norat T, Riboli E. Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2018;28(6):543–56.CrossRef
41.
go back to reference Sahebkar M, Heidarian Miri H, Noormohammadpour P, et al. Prevalence and correlates of low physical activity in the Iranian population: national survey on non-communicable diseases in 2011. Scand J Med Sci Sports. 2018;28(8):1916–24.CrossRef Sahebkar M, Heidarian Miri H, Noormohammadpour P, et al. Prevalence and correlates of low physical activity in the Iranian population: national survey on non-communicable diseases in 2011. Scand J Med Sci Sports. 2018;28(8):1916–24.CrossRef
42.
go back to reference Dashtian M, Eftekhar Ardebili H, Karimzadeh Shirazi K, Shahmoradi M, Azam K. Predicting factors affecting medication adherence and physical activity in patients with type-2 diabetes mellitus based on the theory of planned behavior. J School Public Health Inst Public Health Res. 2017;15(2):133–46. Dashtian M, Eftekhar Ardebili H, Karimzadeh Shirazi K, Shahmoradi M, Azam K. Predicting factors affecting medication adherence and physical activity in patients with type-2 diabetes mellitus based on the theory of planned behavior. J School Public Health Inst Public Health Res. 2017;15(2):133–46.
43.
go back to reference Bergman P, Grjibovski AM, Hagströmer M, Bauman A, Sjöström M. Adherence to physical activity recommendations and the influence of socio-demographic correlates—a population-based cross-sectional study. BMC Public Health. 2008;8(1):367.CrossRef Bergman P, Grjibovski AM, Hagströmer M, Bauman A, Sjöström M. Adherence to physical activity recommendations and the influence of socio-demographic correlates—a population-based cross-sectional study. BMC Public Health. 2008;8(1):367.CrossRef
44.
go back to reference Alkerwi A, Schuh B, Sauvageot N, et al. Adherence to physical activity recommendations and its associated factors: an interregional population-based study. J Public Health Res. 2015;4(1):406. Alkerwi A, Schuh B, Sauvageot N, et al. Adherence to physical activity recommendations and its associated factors: an interregional population-based study. J Public Health Res. 2015;4(1):406.
Metadata
Title
Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes
Authors
Alireza Mirahmadizadeh
Haniyeh Khorshidsavar
Mozhgan Seif
Mohammad Hossein Sharifi
Publication date
01-02-2020
Publisher
Springer Healthcare
Keyword
Type 2 Diabetes
Published in
Diabetes Therapy / Issue 2/2020
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-019-00750-8

Other articles of this Issue 2/2020

Diabetes Therapy 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.